Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 4e-05 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0002 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |